Publications

  1. Gonzalez-Stawinski GV, Cook DJ, Chui J, Gupta S, Navia JL, Hoercher K, Taylor DO, Yamani MH, Starling RC, Smedira NG. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection. J Surg Res. 2007 Oct; 142(2):233-8. Epub 2007 Aug 29.
    View PubMed
  2. Yamani MH, Taylor DO, Haire C, Smedira N, Starling RC. Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression. Clin Transplant. 2007 Jul-Aug; 21(4):523-5.
    View PubMed
  3. Gonzalez-Stawinski GV, Cook DJ, Smedira NG, Navia JL, Taylor DO, Yamani MH, Hoercher K, Starling RC, Banbury MK. Attrition from heart transplant waiting list for patients on ventricular assist devices is not affected by desensitization strategies. Transplant Proc. 2007 Jun; 39(5):1571-2.
    View PubMed
  4. Baris N, Sipahi I, Kapadia SR, Nicholls SJ, Erinc K, Gulel O, Crowe TD, Hobbs R, Yamani MH, Taylor DO, Smedira N, Starling RC, Nissen SE, Tuzcu EM. Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade. J Heart Lung Transplant. 2007 Jun; 26(6):593-7.
    View PubMed
  5. Yamani MH, Taylor DO, Rodriguez ER, Cook DJ, Zhou L, Smedira N, Starling RC. Transplant vasculopathy is associated with increased AlloMap gene expression score. J Heart Lung Transplant. 2007 Apr; 26(4):403-6.
    View PubMed
  6. Yamani MH, Starling RC. Heart transplantation: a magnified model of heart-brain interactions. Cleve Clin J Med. 2007 Feb; 74 Suppl 1:S110-3.
    View PubMed
  7. Tayara W, Starling RC, Yamani MH, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 2006 May; 25(5):504-9. Epub 2006 Mar 30.
    View PubMed
  8. Haji SA, Avery RK, Yamani MH, Tuzcu EM, Crowe TD, Cook DJ, Mawhorter SD, Hobbs R, Young JB, Smedira N, Starling RC. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy. J Heart Lung Transplant. 2006 Mar; 25(3):294-7. Epub 2006 Jan 06.
    View PubMed
  9. Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC. Working group on molecular testing in cardiac transplantation. Molecular testing in the management of cardiac transplant recipients JHLT. 2006; 25(12):1389-95.
  10. Gonzales-Stawinski G, Cook DJ, Chang AS, Banbury M, Navia J, Hoercher K, Lober C, Atik FA, Taylor DO, Yamani MH, Young JB, Starling RC, Smedira N. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant. 2006; 25:613-8.
  11. Yamani MH, Chuang HH, Ozduran V, Avery RK, Mawhorter SD, McNeill A, Cook DJ, Buda T, Hobbs RE, Taylor DO, Smedira NG, Starling RC. The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation J Heart Lung Transplant. 2006; 25(7):820-4.
  12. Sigurdsson G, Carrascosa P, Yamani MH, Greenberg NL, Perrone S, Lev G, Desai MY, Garcia MJ. Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multisegment reconstruction. JACC. 2006; 48(4):772-8.
  13. Yamani MH, Cook DJ, Rodriguez ER, Thomas DM, Gupta S, Alster J, Taylor DO, Hobbs R, Young JB, Smedira N, Starling RC. Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection. JHLT. 2006; 25:1283-9.
  14. Pervaiz MH, Dickinson MG, Yamani MH. Is Digoxin a drug of the past? Cleveland Clinic J Med. 2006; 73(9):821-38.
  15. Ozduran V, Yamani MH, Chuang HH, Sipahi I, Cook DJ, Sendrey D, Tong L, Hobbs R, Rincon G, Bott-Silverman C, James K, Taylor DO, Young JB, Navia J, Banbury M, Smedira N, Starling RC. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. Transplant Proc. 2005 Dec; 37(10):4509-12.
    View PubMed
  16. Poggio ED, Roddy M, Riley J, Clemente M, Hricik DE, Starling R, Young JB, Gus B, Yamani MH, Heeger PS. Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy. J Heart Lung Transplant. 2005 Oct; 24(10):1606-13.
    View PubMed
  17. Erinc K, Yamani MH, Starling RC, Crowe T, Hobbs R, Bott-Silverman C, Rincon G, Young JB, Feng J, Cook DJ, Smedira N, Tuzcu EM. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. J Heart Lung Transplant. 2005 Aug; 24(8):1033-8.
    View PubMed
  18. O’Neill JO, McRae AT, Troughton RW, Ng K, Taylor DO, Yamani MH, Young JB, Starling RC. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant. 2005; 24(4):416-20.
  19. Yamani MH, Cook DJ, Tuzcu EM, Paul P, Ratliff NB, Yu Y, Hobbs R, Rincon G, Bott-Silverman C, Smedira N, Young JB, Starling RC. Systemic activation of integrin αvβ3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient. J Heart Lung Transplant. 2005; 24(8):1015-18.
  20. Yamani MH, Ratliff NB, Cook DJ, Tuzcu EM, Yu Y, Hobbs R, Rincon G, Bott-Silverman C, Young JB, Smedira N, Starling RC. Peri-transplant ischemic injury is associated with cardiac chimerism and upregulation of stromal cell-derived factor-1 (SDF-1). J Am Coll Card. 2005; 46(6):1029-35.
  21. Yamani MH, Avery R, Mawhorter SD, McNeill A, Cook DJ, Ratliff NB, Pelegrin D, Colosimo PJ, Kiefer K, Ludrosky K, Hobbs R, Taylor D, Buda T, Yeager M, Young JB, Smedira N, Starling RC. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single center study. J Heart Lung Transplant. 2005; 24(11):1766-9.
  22. Yamani MH, Erinc SK, McNeill A, Ratliff NB, Sendrey D, Zhou L, Cook DJ, Hobbs R, Rincon G, Bott-Silverman C, Young JB, Banbury M, Navia J, Smedira N, Starling RC. The impact of donor gender on cardiac peri-transplant ischemic injury. J Heart Lung Transplant. 2005; 24(11):1741-44.
  23. Erinc K, Yamani MH, Starling RC, Young JB, Crowe T, Ratliff NB, Cook DJ, Hobbs R, Bott-Silverman C, Rincon G, Smedira N, Tuzcu EM. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound. Transplant Proc. 2004 Dec; 36(10):3129-31.
    View PubMed
  24. Goetze S, Sigurdsson G, Greenberg NL, Yamani H, Garcia MJ. Images in cardiovascular medicine. Transplant vasculopathy: evaluation with multi-detector computed tomography. Circulation. 2004 Aug 31; 110(9):e80-1.
    View PubMed
  25. Nash PJ, Avery RK, Tang WH, Starling RC, Taege AJ, Yamani MH. Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant. 2004 Jul; 4(7):1200-3.
    View PubMed
  26. Yamani MH, Cook DJ, Tuzcu EM, Abdo A, Paul P, Ratliff NB, Yu Y, Yousufuddin M, Feng J, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB, Starling RC. Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am J Transplant. 2004 Jul; 4(7):1097-102.
    View PubMed
  27. Yousufuddin M, Haji S, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Saad Y, Karnik SS, Wang D, McCarthy PM, Young JB, Yamani MH. Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation. Eur Heart J. 2004 Mar; 25(5):377-85.
    View PubMed
  28. Haji SA, Starling RC, Avery RK, Mawhorter S, Tuzcu EM, Schoenhagen P, Cook DJ, Ratliff NB, McCarthy PM, Young JB, Yamani MH. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant. 2004 Mar; 23(3):277-83.
    View PubMed
  29. Yamani MH, Yousufuddin M, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant. 2004; 2(3):272-76.
  30. Yamani MH, Lauer MS, Starling RC, Pothier CE, Tuzcy EM, Ratliff NB, Cook DJ, Abdo A, McNeill A, Crowe T, Hobbs, R, Rincon G, Bott-Silverman CB, McCarthy PM, Young JB. Impact of donor spontaneous intracranial hemorrhage on outcome following heart transplantation. Am J Transplant. 2004; 4:257-61.
  31. Yousufuddin M, Cook DJ, Starling RC, Abdo A, Paul P, Tuzcu EM, Ratliff NB, McCarthy P, Young JB, Yamani MH. Angiotensin II type receptors from peri-operation through first year post-transplantation and the risk of transplant coronary artery disease. J Am Coll Card. 2004; 43(9):1565-73.
  32. Yousufuddin M, Yamani MH. The renin–angiotensin hypothesis for the pathogenesis of cardiac allograft vasculopathy. Int J Card. 2004; 95(2-3):123-7.
  33. Yamani MH, Erinc K, Starling RC, Young JB, Ratliff NB, Cook DJ, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, Bennett R, Smedira N, Tuzcu EM. Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy: Evidence from intravascular ultrasound. Transplant Proc. 2004; 36(9):2564-66.
  34. Yamani MH, Starling RC. Surrogate markers of transplant vasculopathy. Curr Opin Organ Transplant. 2004; 9:443-7.
  35. Masri SC, Yamani MH, Russell MA, Ratliff NB, Yang J, Almasan A, Apperson-Hansen C, Li J, Starling RC, McCarthy P, Young JB, Bond M. Sustained apoptosis in human cardiac allografts despite histologic resolution of rejection. Transplantation. 2003 Sep 15; 76(5):859-64.
    View PubMed
  36. Fahmy NM, Yamani MH, Starling RC, Ratliff NB, Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts. Transplantation. 2003 Jun 27; 75(12):2044-7.
    View PubMed
  37. Fahmy NM, Yamani MH, Starling RC, Ratliff NB, Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation. 2003 Jan 15; 75(1):72-8.
    View PubMed
  38. Khot UN, Mishra M, Yamani MH, Smedira NG, Paganini E, Yeager M, Buda T, McCarthy PM, Young JB, Starling RC. Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. J Am Coll Card. 2003; 41(3):381-5.
  39. Yamani MH, Starling RC, Cook DJ, Tuzcu EM, Abdo A, Paul P, Powell K, Ratliff NB, Yu Y, McCarthy PM, Young JB. Donor spontaneous intracerebral hemorrhage is associated with systemic activation of MMP-2 and MMP-9 and subsequent development of coronary vasculopathy in the heart transplant recipient. Circulation. 2003; 108:1724-28.
  40. Ferri C, Properzi G, Tomassoni G, Santucci A, Desideri G, Giuliani AE, Starling RC, Ratliff NB, Cook DJ, McCarthy P, Young JB, Yamani MH. Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation. 2002 Apr 16; 105(15):1768-71.
    View PubMed
  41. Yamani MH, Yang J, Masri S, Ratliff NB, Bond M, Starling RC, McCarthy P, Plow E, Young JB. Acute cellular rejection is associated with increased expression of vitronectin receptor (Integrin alphavbeta3). Am J Transplantation. 2002; 2:129-33.
  42. Yamani MH, Masri S, Ratliff NB, Bond M, Starling RC, Tuzcu M, McCarthy P, Young JB. The role of vitronectin receptor (alphavbeta3) and tissue factor in the pathogenesis of transplant vasculopathy. J Am Coll Cardiol. 2002; 39(5):804-10.
  43. Yamani MH, Haji SA, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, Abdo A, Crowe T, McCarthy PM, Young JB. Myocardial ischemic-fibrotic injury following human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection, and poor long-term outcome. J Am Coll Cardiol. 2002; 39:970-77.
  44. Yamani MH, Tuzcu EM, Starling RC, Young JB, Hobbs R, Cook DJ, Haji SA, Abdo S, Crowe T, Secic M, McCarthy PM, Ratliff NB. A novel method based on computerized scoring of histopathology for the prediction of coronary vasculopathy, validated by Intravascular Ultrasound. J Heart Lung Transplant. 2002; 21(8):850-59.
  45. Yamani MH, Tuzcu EM, Starling RC, Ratliff NB, Yu Y, Vince GD, Powell K, Cook D, McCarthy P, Young JB. Myocardial ischemic injury following heart transplantation is associated with upregulation of vitronectin receptor (alphavbeta3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy. Circulation. 2002; 105:1955-61.
  46. Yamani MH, Starling RC, Young JB, Cook D, Yu Y, Geoffrey V, McCarthy P, Ratliff NB. Acute vascular rejection is associated with up-regulation of vitroncetin receptor (alpha v beta 3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J Heart Lung Transplant. 2002; 21(9):983-9.
  47. Yamani MH, Kinter MT, Starling RC, Willard BB, Ratliff NB, Yu Y, Cook D, McCarthy M, Young JB. Increased beta-myosin heavy chain in acute cellular rejection following human heart transplantation. Am J Transplantation. 2002; 2:386-8.
  48. Yamani MH. Diastolic heart failure. Men’s Health Advisor; 2002; 4(8):6-7.
  49. Yamani MH, Young J. Chemokines in cardiovascular diseases: from atherosclerosis and heart failure to allograft arteriopathy. Graft. 2002; 5(4):205-11.
  50. Yamani MH, Haji S, Starling RC, Kelly L, Albert N, Knack DL, Young JB. Comparison between Dobutamine and Milrinone based therapy for acute exacerbation of congestive heart failure: hemodynamic efficacy, clinical outcome, and economic cost. Am Heart J. 2001 Dec; 142(6):998-1002.
  51. Shen B, Younossi ZM, Dolmatch B, Newman JS, Henderson JM, Ong JP, Gramlich T, Yamani M. Patent ductus venosus in an adult presenting as pulmonary hypertension, right-sided heart failure, and portosystemic encephalopathy. Am J Med. 2001 Jun 1; 110(8):657-60.
    View PubMed
  52. Jimenez J, Kapadia SR, Yamani MH, Platt L, Hobbs RE, Rincon G, Botts-Silverman C, Starling RC, Young JB, Nissen SE, Tuzcu M, Ratliff NB. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant. 2001 Apr; 20(4):393-8.
    View PubMed
  53. Yamani MH, Avery R, Mawhorter S, Young JB, Hobbs R, McCarthy PM, Smedira N, Hoercher K, Ratliff NB, Goormastic M, Pelegrin D, Starling RC. Hypogammaglobulinemia following cardiac transplantation: a link between infection and acute cellular rejection. J Heart Lung Transplant. 2001; 20(4):425-30.
  54. Yamani MH, Avery R, Mawhorter S, Young JB, McNeill A, Cook DJ, Ratliff NB, McCarthy P, Starling RC. Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes. Transplant Infectious Disease. 2001; 3:40-3.
  55. Yamani MH. When should digoxin be used in patients with diastolic dysfunction. The Cleveland Clinic J of Med. 2001; 68(6):481-5.
  56. Yamani MH, Starling RC. Long-term medical complications of heart Transplantation: Information for the Primary Care Physician. The Cleveland Clinic J of Med. 2000; 67(9):673-81.
  57. Cook DJ, Bishay ES, Yamani MH. The use and misuse of Immunologic Monitoring after transplantation. Curr Opinion Cardiol J. 2000; 15:104-7.
  58. Yamani MH, Starling RC, Pelegrin D, Platt L, Majercik M, Hobbs RE, Mc Carthy P, Young JB. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. J Heart and Lung Transplant. 2000; 19:337-42.
  59. Yamani MH, Starling RC, Van Lente F, Goormastic M, Smedira N, McCarthy P, Young JB. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. Transplantation. 2000; 69(11):2326-30.
  60. Yamani MH, van de Poll S, Ratliff NB, Kuban BE, Starling RC, McCarthy P, Young JB. Fluorescence spectroscopy of endomyocardial tissue post human heart transplantation: Does it correlate with histopathology. J Heart Lung Transplant. 2000; 19:1077-80.
  61. Yamani MH, Wells L, Massie BM, Ammon S, Der E, Prouty K. Relation of the nine-minute self-powered treadmill test to maximal exercise capacity and skeletal muscle function in patients with congestive heart failure. Am J Cardiol. 1995 Oct 15; 76(11):788-92.
    View PubMed
  62. Yamani MH, Sahgal P, Wells L, Massie BM. Exercise intolerance in chronic heart failure is not associated with impaired recovery of muscle function or submaximal exercise performance J Am Coll Card. 1995; 25(6):1232-38.
  63. Yamani MH, Massie BM. Hypertension, myocardial ischemia, sudden death Curr Opin Cardiol. 1994; 9(5):542-50.
  64. Yamani M, Massie BM. Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin Proc. 1993; 68(12):1214-18.
  65. Malouf J, Yamani M, Dagher I, Kaid S, Alam S. Two dimensional echocardiographic demonstration of an unusual complication of aortic infective endocarditis. Acta Cardiol. 1984; 39(5):379-86.
    View PubMed